A High-Performance Liquid Chromatography–Tandem Mass Spectrometry Assay of the Androgenic Neurosteroid 3α-Androstanediol (5α-Androstane-3α,17β-Diol) in Plasma

    July 2005 in “ Steroids
    Doodipala Samba Reddy, L VENKATARANGAN, Ben Chien, Kumar Ramu
    TLDR Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.
    The study developed a high-performance liquid chromatography–tandem mass spectrometry (LC–MS–MS) method to measure the androgenic neurosteroid 3α-androstanediol in rat plasma, demonstrating excellent linearity, specificity, sensitivity, and reproducibility. The method showed a sensitivity of <10 ng/ml and a detection limit of 2 ng/ml. It was used to analyze testosterone-induced increases in plasma 3α-androstanediol levels, revealing that testosterone elevates 3α-androstanediol levels in a dose-dependent manner, which was inhibited by the 5α-reductase inhibitor finasteride. This indicated that 3α-androstanediol is synthesized from testosterone via a 5α-reductase pathway. The study also suggested the potential role of 3α-androstanediol in modulating GABAA receptor activity and its implications for seizure control, although the assay faced limitations in analyzing physiological concentrations.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Research

    7 / 7 results